This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Intercept Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2023 was $8.164. Intercept Pharmaceuticals's 10-Year median PS Ratio is 17.0676. Therefore, the Median PS Value for today is $139.34.
As of today (2023-05-28), Intercept Pharmaceuticals's share price is $10.26. Intercept Pharmaceuticals's Median PS Value is $139.34. Therefore, Intercept Pharmaceuticals's Price to Median PS Value for today is 0.07.
The historical rank and industry rank for Intercept Pharmaceuticals's Median PS Value or its related term are showing as below:
ICPT'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.06 Med: 0.08 Max: 0.1
Current: 0.07
During the past 13 years, the highest Price to Median PS Value of Intercept Pharmaceuticals was 0.10. The lowest was 0.06. And the median was 0.08.
ICPT's Price-to-Median-PS-Value is ranked better than 95.92% of 245
companies
in the Biotechnology industry
Industry Median: 0.64
vs ICPT: 0.07
Intercept Pharmaceuticals Median PS Value Historical Data
The historical data trend for Intercept Pharmaceuticals's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Intercept Pharmaceuticals Annual Data
Trend
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Median PS Value
-
-
-
-
157.17
Intercept Pharmaceuticals Quarterly Data
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Median PS Value
276.07
201.78
184.84
157.17
139.34
Competitive Comparison
For the Biotechnology subindustry, Intercept Pharmaceuticals's Median PS Value, along with its competitors' market caps and Median PS Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Intercept Pharmaceuticals Median PS Value Distribution
For the Biotechnology industry and Healthcare sector, Intercept Pharmaceuticals's Median PS Value distribution charts can be found below:
* The bar in red indicates where Intercept Pharmaceuticals's Median PS Value falls in comparison to its industry or sector. The grey bar indicates the Median PS Value's extreme value range as defined by GuruFocus.
Intercept Pharmaceuticals Median PS Value Calculation
Intercept Pharmaceuticals's Median PS Value for today is calculated as
10-Year Median PS Ratio is 17.0676.
Intercept Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.164.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intercept Pharmaceuticals (NAS:ICPT) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Intercept Pharmaceuticals's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
10.26
/
139.34
=
0.07
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intercept Pharmaceuticals Median PS Value Related Terms
Thank you for viewing the detailed overview of Intercept Pharmaceuticals's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Intercept Pharmaceuticals (NAS:ICPT) Business Description
Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor. OCA was approved as Ocaliva to treat primary biliary cirrhosis in 2016 and is being developed for a variety of chronic liver diseases, including nonalcoholic steatohepatitis, or NASH.
Create New Portfolio
Portfolio Contest
Personalize
Premium Gurus 
0.51(5.23%) Volume: 1,489,063 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
ICPT has been successfully added to your 
